Candriam Luxembourg S.C.A. Acquires Shares of 6,000 MAXIMUS, Inc. (NYSE:MMS)

Candriam Luxembourg S.C.A. purchased a new position in MAXIMUS, Inc. (NYSE:MMS) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 6,000 shares of the health services provider’s stock, valued at approximately $391,000.

Several other institutional investors also recently bought and sold shares of the stock. Oregon Public Employees Retirement Fund boosted its stake in MAXIMUS by 6,329.9% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,656,085 shares of the health services provider’s stock valued at $25,000 after purchasing an additional 1,630,329 shares during the last quarter. Quantamental Technologies LLC purchased a new stake in MAXIMUS during the 4th quarter valued at $38,000. Tributary Capital Management LLC purchased a new stake in MAXIMUS during the 4th quarter valued at $52,000. Advisor Group Inc. boosted its stake in MAXIMUS by 47.3% during the 4th quarter. Advisor Group Inc. now owns 869 shares of the health services provider’s stock valued at $56,000 after purchasing an additional 279 shares during the last quarter. Finally, Huntington National Bank boosted its stake in MAXIMUS by 262.5% during the 4th quarter. Huntington National Bank now owns 928 shares of the health services provider’s stock valued at $60,000 after purchasing an additional 672 shares during the last quarter. Institutional investors own 95.49% of the company’s stock.

Several brokerages have commented on MMS. Zacks Investment Research downgraded MAXIMUS from a “buy” rating to a “sell” rating in a research note on Friday, April 12th. ValuEngine downgraded MAXIMUS from a “buy” rating to a “hold” rating in a research note on Thursday, February 28th.

Shares of NYSE MMS traded up $0.19 during midday trading on Friday, hitting $70.97. 199,146 shares of the stock traded hands, compared to its average volume of 249,063. The stock has a market capitalization of $4.53 billion, a price-to-earnings ratio of 20.87, a PEG ratio of 1.94 and a beta of 0.96. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.32 and a quick ratio of 2.32. MAXIMUS, Inc. has a one year low of $60.00 and a one year high of $73.81.

MAXIMUS (NYSE:MMS) last released its quarterly earnings results on Thursday, February 7th. The health services provider reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.06. The firm had revenue of $664.60 million for the quarter, compared to analysts’ expectations of $672.08 million. MAXIMUS had a return on equity of 20.09% and a net margin of 8.94%. The company’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.89 EPS. Equities research analysts anticipate that MAXIMUS, Inc. will post 3.66 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.00 annualized dividend and a dividend yield of 1.41%. MAXIMUS’s payout ratio is 29.41%.

In other news, Director Paul R. Lederer sold 6,715 shares of the stock in a transaction on Wednesday, February 13th. The stock was sold at an average price of $70.04, for a total transaction of $470,318.60. Following the transaction, the director now directly owns 59,029 shares of the company’s stock, valued at approximately $4,134,391.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Russell A. Beliveau sold 1,000 shares of the stock in a transaction on Monday, April 1st. The shares were sold at an average price of $71.40, for a total value of $71,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 54,715 shares of company stock worth $3,873,949 over the last three months. Insiders own 2.20% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Baseball Daily News and is the property of of Baseball Daily News. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/candriam-luxembourg-s-c-a-invests-391000-in-maximus-inc-mms.html.

MAXIMUS Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.

Featured Story: What is a short straddle?

Institutional Ownership by Quarter for MAXIMUS (NYSE:MMS)

Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.